Yin Xiang Selected Research

Adenocarcinoma of Lung

1/2017	MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145.
10/2015	The lncRNA MALAT1 protects the endothelium against ox-LDL-induced dysfunction via upregulating the expression of the miR-22-3p target genes CXCR2 and AKT.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yin Xiang Research Topics

Disease

3	Neoplasm Metastasis (Metastasis) 04/2024 - 10/2015
3	Neoplasms (Cancer) 12/2023 - 01/2017
3	Coronary Artery Disease (Coronary Atherosclerosis) 10/2015 - 01/2015
2	Atherosclerosis 04/2024 - 10/2015
2	Hypoxia (Hypoxemia) 03/2021 - 01/2017
2	Atrial Fibrillation 01/2021 - 09/2017
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2017 - 01/2017
2	Reperfusion Injury 01/2017 - 01/2017
2	Adenocarcinoma of Lung 01/2017 - 10/2015
2	Cardiomyopathies (Cardiomyopathy) 01/2015 - 01/2015
1	Carcinogenesis 04/2024
1	Lung Neoplasms (Lung Cancer) 12/2023
1	Circulating Neoplastic Cells 12/2023
1	Myocardial Infarction 03/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Heart Failure 01/2022
1	Endotoxemia 11/2021
1	Liver Neoplasms (Liver Cancer) 11/2021
1	Hepatocellular Carcinoma (Hepatoma) 11/2021
1	Respiratory Syncytial Virus Infections 01/2020
1	Ischemia 01/2020
1	Tachycardia (Tachyarrhythmias) 09/2017
1	Infarction (Infarctions) 01/2017
1	Hyperplasia 01/2017
1	Infections 01/2017
1	Thrombosis (Thrombus) 01/2015
1	Hemorrhage 01/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2015
1	Heart Diseases (Heart Disease) 01/2015
1	Jaundice (Icterus) 07/2012
1	Pancreatitis 07/2012
1	Vomiting 07/2012
1	Abdominal Pain (Pain, Abdominal) 07/2012

Drug/Important Bio-Agent (IBA)

4	Long Noncoding RNAIBA 04/2024 - 10/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2017
2	ThioredoxinsIBA 01/2017 - 01/2017
2	MicroRNAs (MicroRNA)IBA 10/2015 - 10/2015
2	radix ophiopogonis drug combination radix ginseng fructus schizandrae (Shen Mai)IBA 01/2015 - 01/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015 - 01/2015
1	LigandsIBA 12/2023
1	Nucleic AcidsIBA 02/2023
1	Proteins (Proteins, Gene)FDA Link 02/2023
1	Phospholipids (Phosphatides)FDA LinkGeneric 02/2023
1	Evans Blue (Blue, Evans)FDA Link 03/2022
1	GinsenosidesIBA 03/2021
1	TubulinIBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2017
1	EnzymesIBA 01/2017
1	ginsenoside Rg1IBA 01/2017
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 10/2015
1	Protein Kinases (Protein Kinase)IBA 10/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2015
1	omega-Chloroacetophenone (Mace)IBA 01/2015
1	cangrelorIBA 01/2015
1	Caspase 12IBA 01/2015

Therapy/Procedure

2	Therapeutics 02/2023 - 01/2015
2	Catheter Ablation 01/2021 - 09/2017
2	Stents 01/2015 - 07/2012
1	Nutritional Support (Artificial Feeding) 11/2021
1	Hepatectomy 11/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2017
1	Drug Therapy (Chemotherapy) 01/2015
1	Intravenous Administration 01/2015